Gavilimomab

DB06545InvestigationalProtein Based Therapies

Investigated for use/treatment in graft versus host disease.

Protein structure of Gavilimomab
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in graft versus host disease.Curator reviewed
Code names
ABX-CBL

Resolves to

Compound
UNIITCR92293RCCAS244096-20-6
Targets
P35613BSG

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gavilimomab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In